The annual Crnic Institute Down Syndrome Research Symposium showcases the most innovative Down syndrome research at the University of Colorado and will be held in-person on September 21, 2022.
Crnic Institute researchers’ discovery could lead to more effective COVID treatment with immune modulatory drugs
One of our newest research initiatives is an NIH-funded clinical trial testing the safety and efficacy of a drug called tofacitinib
Our scientists, data analysts, and administrators have teamed up with Children's Hospital of Philadelphia and Sage Bionetworks for this new initiative
The Trial-Ready Cohort-Down Syndrome (TRC-DS) matches people with Down syndrome to clinical trials studying DS related Alzheimer’s disease.